Key takeaways
- 1Pharmaceutical assistance, copay assistance, disease charities and government schemes often stack — people frequently qualify for more than one.
- 2Assemble one reusable document pack: identity, income evidence, household size, insurance details, prescription and a short hardship note.
- 3Most rejections are administrative, not substantive — names matching identity documents exactly, no blanks, and follow-ups in writing.
- 4Legitimate programmes never charge an application fee; any service demanding one should be treated as suspicious.
On this page
1Four kinds of help, often stackable
These are distinct systems with different eligibility rules, and people frequently qualify for more than one at the same time.
| Type | Who runs it | Typical benefit | Usual requirement |
|---|---|---|---|
| Manufacturer assistance | Pharmaceutical company | Free or heavily discounted brand | Income test, prescription, residency |
| Copay assistance | Pharmaceutical company | Reduced out-of-pocket per fill | Commercial insurance, not public |
| Charitable foundation | Disease-specific non-profit | Grant toward costs | Diagnosis and income criteria |
| Government scheme | National or regional health system | Capped or free prescriptions | Residency, age, income or condition |
2Prepare the document pack once
Most rejections are administrative, not substantive — missing signatures, expired documents, mismatched names. Assembling one complete pack lets you apply to several programmes quickly.
- 1Proof of identity and residency or immigration status where required.
- 2Recent income evidence — tax return, payslips or benefit statements.
- 3Household size documentation, since thresholds are usually per household.
- 4Insurance details, including a denial letter if coverage was refused.
- 5A current prescription with exact medicine name, strength and dose.
- 6The prescriber's signature section, completed and dated.
- 7A short cover letter describing the financial hardship in plain terms.
3How to improve your odds
Applications are assessed against written criteria, so precision matters more than eloquence.
- Apply before you run out, not after — processing takes weeks.
- Use exactly the name that appears on your identity documents everywhere.
- Answer every field; blanks are treated as incomplete rather than not applicable.
- Include the diagnosis code if the programme is condition-specific.
- Keep copies of everything you send, with dates.
- Follow up in writing after two weeks and record who you spoke to.
- If refused, ask for the specific reason — many refusals are correctable and resubmittable.
What the Jivan dataset shows
- 59×
- average price gap
- 84%
- of anchors exceed 10×
- 344×
- widest documented gap
Across our full referenced dataset, 476 referenced molecules average a 59× price gap, 84% of them are at least 10× cheaper in India, and the widest documented comparison is Colchicine at 344×. Across the full referenced dataset the gap is systematic rather than anecdotal: 84% of anchored molecules are at least 10× cheaper, with a 59× average ratio — a market-structure effect repeated across all 26 therapy areas.
Computed live from 476 anchors
Frequently asked questions
Not always. Some programmes require you to be uninsured or underinsured; copay assistance schemes typically require commercial insurance. Read each programme's criteria rather than assuming.
Commonly two to six weeks, though some programmes offer expedited review for urgent clinical need. Apply well before your current supply runs out.
Yes, though usually for different medicines. Assistance tends to be most valuable for on-patent branded therapy, while generic substitution handles off-patent items.
Sources and further reading
Every factual claim above is traceable to a public primary source. We cite regulators and public health bodies rather than commercial sellers.
- 1Health Costs and Prescription Drug ResearchKFF (Kaiser Family Foundation)
- 2NHS Prescription Costs and Help with CostsNational Health Service, UK
- 3Pradhan Mantri Bhartiya Janaushadhi PariyojanaGovernment of India
- 4MedlinePlus Drug InformationU.S. National Library of Medicine
How this article was made
Written and researched
Health Affordability Editor, Jivan Editorial TeamEditorially reviewed
Editorial Review Board — Jivan
Sources checked against Tier-1/Tier-2 references.
Important medical safety notice
Always consult a licensed physician before changing medicine, dose, or brand. Jivan provides educational pricing intelligence and does not replace emergency or diagnostic care.